References
- Gilbard JP. Dry eye, blepharitis and chronic eye irritation: divide and conquer. J Ophthalmic Nurs Technol 1999;18: 109–15
- Bron AJ. Diagnosis of dry eye. Surv Ophthalmol 2001;45 (Suppl 2):S221–S226
- Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997;74:624–31
- Schirra F, Ruprecht KW. Dry eye. An update on epidemiology, diagnosis, therapy and new concepts. Ophthalmologe 2004;101:10–8
- Perry HD, Donnenfeld ED. Topical 0.05% cyclosporine in the treatment of dry eye. Expert Opin Pharmacother 2004;5: 2099–107
- Moss Se, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264–8
- Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25:900–7
- Sun J, Liu C, Zhang Y, Ang H. Effect of cyclosporine A eye drop on keratoconjunctivitis sicca and its mechanism. J Huazhong Univ Sci Technolog Med Sci 2005;25:738–40
- Sall K, Stevenson OD, Mundorf TK, Reis BL; the CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 2000;107:631–9
- Data on file. Internal File Number 5124277. Allergan, Irvine, CA
- Horio M, Ito A, Matsuoka Y, et al. Apoptosis induced by hyper-tonicity in Madin Darley canine kidney cells: protective effect of betaine. Nephrol Dial Transplant 2001;16:483–90
- Alfieri RR, Cavazzoni A, Petronini PG, et al. Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol 2002;540:499–508
- de Zengotita VM, Abston LR, Schmelzer AE, et al. Selected amino acids protect hybridoma and CHO cells from elevated carbon dioxide and osmolality. Biotechnol Bioeng 2002;78: 741–52
- Simmons PA, Garret Q, Xu S, et al. Interaction of carboxymethylcellulose with human corneal cells. Presented at: the annual meeting of the Association for Research in Vision and Ophthalmology, April 30–May 4, 2006; Ft. Lauderdale, FL. Program No. 2759
- Hunt G, Kearney P, Kellaway IW. Mucoadhesive polymers in drug delivery systems. In: Johnson P, Lloyd-Jones JG, editors. Drug delivery systems: fundamentals and techniques. New York (NY): VCH Publ. Inc; 1987. p. 180–98
- Sall KN, Cohen SM, Christensen MT, Stein JM. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. Eye Contact Lens 2006;32:21–6
- Noecker RJ. Comparison of initial treatment response to two enhanced-viscosity artificial tears. Eye Contact Lens 2006;32:148–52
- Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006;47:4309–15
- McCulley JP, Aronowicz JD, Uchiyama E, et al. Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact. Am J Ophthalmol 2006;141:758–60